Literature DB >> 8709079

Dependence of retinopathy (and other complications) on glycaemic control and on weight over 5/10 years from diagnosis of type II diabetes.

B J Boucher1, J Tsoumanis, K Noonan, J Holmes.   

Abstract

Glycosylated haemoglobins and weights were recorded for 200 consecutive diabetic clinic attenders seen yearly for 5 years, 76 of whom were also seen up to 10 years from diagnosis of type 2 diabetes, representing 1380 patient years. Weight fluctuation (> 3 kg) was associated with increased final prevalence of hypertension, macroalbuminaemia and a raised creatinine (P < 0.002) but this relationship was abolished by correction for higher initial weight. Average glycaemia over 5/10 years [itself related to initial weight in women on tablets (N = 53) but not others, and to waist but not waist/hip ratio], correlated with prevalence and severity of retinopathy (N = 200; r = 0.38, P < 0.0006) seen also in the subgroup of patients on tablets (N = 145, P < 0.006). At HbA1 levels > 10.5% an increased prevalence of retinopathy was seen in those on insulin (N = 37, P < 0.001) and an increased prevalence of peripheral vascular disease was seen in men but not women (x2 = 2.87, P < 0.01) as well as in the prevalence of neuropathy. These findings suggest that good glycaemic control is of value in type 2 diabetes and less easily achieved in obesity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8709079      PMCID: PMC1295638          DOI: 10.1177/014107689608900108

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


  9 in total

1.  Quantitiative determination of glycosylated hemoglobin A1 by agar gel electrophoresis.

Authors:  L Menard; M E Dempsey; L A Blankstein; H Aleyassine; M Wacks; J S Soeldner
Journal:  Clin Chem       Date:  1980-10       Impact factor: 8.327

2.  Long-term effects of modest weight loss in type II diabetic patients.

Authors:  R R Wing; R Koeske; L H Epstein; M P Nowalk; W Gooding; D Becker
Journal:  Arch Intern Med       Date:  1987-10

3.  Variability of body weight and health outcomes in the Framingham population.

Authors:  L Lissner; P M Odell; R B D'Agostino; J Stokes; B E Kreger; A J Belanger; K D Brownell
Journal:  N Engl J Med       Date:  1991-06-27       Impact factor: 91.245

4.  Obesity, weight loss and prognosis in type 2 diabetes.

Authors:  M E Lean; J K Powrie; A S Anderson; P H Garthwaite
Journal:  Diabet Med       Date:  1990 Mar-Apr       Impact factor: 4.359

5.  A rapid micro-scale method for the measurement of Haemoglobin A1(a+b+c).

Authors:  S G Welch; B J Boucher
Journal:  Diabetologia       Date:  1978-03       Impact factor: 10.122

6.  The Wisconsin Epidemiologic Study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy.

Authors:  R Klein; B E Klein; S E Moss; K J Cruickshanks
Journal:  Arch Ophthalmol       Date:  1994-09

7.  Relationship between retinopathy and glycaemic control in insulin-dependent and non-insulin-dependent diabetes.

Authors:  J P Monson; G Koios; G C Toms; P G Kopelman; B J Boucher; S J Evans; W L Alexander
Journal:  J R Soc Med       Date:  1986-05       Impact factor: 5.344

8.  Retinopathy in older type II diabetics. Association with glucose control.

Authors:  D M Nathan; D E Singer; J E Godine; C H Harrington; L C Perlmuter
Journal:  Diabetes       Date:  1986-07       Impact factor: 9.461

9.  Elevated long-term glycated haemoglobin precedes proliferative retinopathy and nephropathy in type 1 (insulin-dependent) diabetic patients.

Authors:  C E Kullberg; H J Arnqvist
Journal:  Diabetologia       Date:  1993-10       Impact factor: 10.122

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.